Siemens Healthineers stock rises 1.34 percent on September 25

Published on 09/25/2026 at 13:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

RBC kept its EUR 45 target on September 22. Bernstein set EUR 44.50 and lifted fiscal 2027 adjusted EPS to EUR 2.37 from EUR 2.36, against a 52-week high of EUR 49.71.

Editorial-Foto eines Trading-Floors mit Healthcare-Sektor-Charts und DAX-Anzeige — Siemens Healthineers DE000SHL1006 dokumentiert Börsen-Editorial mit Trading-Floor, Healthcare-Charts und DAX-Kursanzeige im Hintergrund, Illustration mit AI erstellt.

Siemens Healthineers (ISIN DE000SHL1006) stock was trading at EUR 37.71 on Xetra on September 25, 2026, at 11:26 a.m. UTC, up 1.34 percent from EUR 37.21. The latest analyst signals put the market's focus on valuation, product execution and the planned reduction of Siemens AG's stake.

RBC keeps a EUR 45 target

According to MarketScreener on September 22, 2026, RBC kept its Buy rating and a EUR 45 price target for Siemens Healthineers. The target lies 19.3 percent above the EUR 37.71 reference price, giving the analyst view a clear numerical distance from the market quotation.

The same MarketScreener report listed an average analyst target of EUR 45.52 and a mean consensus of Outperform from 20 analysts. Those figures frame the stock's valuation debate, but they do not remove the operational risks identified in current coverage.

Bernstein flags supply pressure

Finimize reported that Bernstein retained an Outperform rating and a EUR 44.50 price target. The firm also raised its fiscal 2027 adjusted earnings per share estimate to EUR 2.37 from EUR 2.36.

The report identified inflation, weaker China diagnostics demand and Siemens AG's planned sell-down as pressure points for 2026 and 2027. For the stock, that creates a split signal: the target prices remain above the quotation, while possible additional share supply can weigh on sentiment before the transaction is completed.

Yearly range shows the gap

At EUR 37.71, Siemens Healthineers stock stood EUR 12.00 below its 52-week high of EUR 49.71 and EUR 4.90 above its 52-week low of EUR 32.81 on September 25, 2026. The price was therefore 24.1 percent below the yearly high, while its market capitalization stood at EUR 42,204,992,360.

Trading volume reached 174,666 shares by 11:26 a.m. UTC on September 25, 2026, and the intraday range ran from EUR 37.41 to EUR 38.01. The combination of a 1.34 percent gain and a position well below the yearly high makes the analyst targets and the Siemens AG stake reduction central reference points for the next valuation move.

Stock gains 1.34 percent

Siemens Healthineers stock was trading at EUR 37.71 on Xetra on September 25, 2026, at 11:26 a.m. UTC, with a daily gain of 1.34 percent from the prior close of EUR 37.21. The quoted price remains below both the EUR 44.50 Bernstein target and the EUR 45 RBC target.